Corporate DisclosureNAVANAPHAR
NAVANAPHAR Corporate Disclosure — 29 January 2026
Announcement summary
- What happened
- NAVANAPHAR published a corporate disclosure on 29 January 2026. Read the full announcement for details.
- Company
- Navana Pharmaceuticals PLC
- Announcement published
Original announcement
The company has informed that the Board of Directors in its meeting held on January 28, 2026, has approved, among others, the following agenda: 1. Approved the generic production project in factory and 2. Approved to establish a subsidiary/liaison office in Sri Lanka.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 697ada8cb322cf5e511aa117
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from NAVANAPHAR
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.